Validations: Tech Transfer & Scale-Up Validation

Cleaning & CCI Impacts in Equivalence: Knock-On Effects to Validate

Cleaning & CCI Impacts in Equivalence: Knock-On Effects to Validate Cleaning & CCI Impacts in Equivalence: Knock-On Effects to Validate Introduction to Process Validation and Its Regulatory Framework Process validation is a critical aspect of pharmaceutical manufacturing that ensures that products are consistently produced to meet quality standards. In the context of regulatory requirements such as FDA process validation, EU…

Continue Reading Cleaning & CCI Impacts in Equivalence: Knock-On Effects to Validate

PPQ Relevance: Using PPQ/CPV Data to Support Equivalence

PPQ Relevance: Using PPQ/CPV Data to Support Equivalence PPQ Relevance: Using PPQ/CPV Data to Support Equivalence In the constantly evolving pharmaceutical landscape, ensuring compliance with regulatory standards is paramount. The adoption of effective processes for Process Performance Qualification (PPQ) and Continued Process Verification (CPV) are critical to ensuring not only compliance with regulations such as FDA process validation and EU…

Continue Reading PPQ Relevance: Using PPQ/CPV Data to Support Equivalence

PPQ Relevance: Using PPQ/CPV Data to Support Equivalence

PPQ Relevance: Using PPQ/CPV Data to Support Equivalence PPQ Relevance: Using PPQ/CPV Data to Support Equivalence Introduction to Process Validation and Its Regulatory Framework Process validation is critical for ensuring that pharmaceutical manufacturing processes yield products that are consistently safe, effective, and of high quality. Under regulations set forth by the FDA, EMA, MHRA, and PIC/S, manufacturers are mandated to…

Continue Reading PPQ Relevance: Using PPQ/CPV Data to Support Equivalence

Case Library: Common Parity Gaps and How to Close Them

Case Library: Common Parity Gaps and How to Close Them Case Library: Common Parity Gaps and How to Close Them The pharmaceutical industry is continually evolving, facing challenges in ensuring compliance with complex regulatory requirements set forth by entities such as the FDA, EMA, and MHRA. This guide serves as a comprehensive resource for understanding common parity gaps in tech…

Continue Reading Case Library: Common Parity Gaps and How to Close Them

Inspection Readiness: Defending Parity/Non-Parity Choices

Inspection Readiness: Defending Parity/Non-Parity Choices Inspection Readiness: Defending Parity/Non-Parity Choices Introduction to Pharmaceutical Validation The principles of pharmaceutical validation are foundational to the production of safe and effective medicines. As pharmaceutical professionals, understanding both the regulatory requirements and the scientific justification for various validation strategies is crucial. In the context of equipment parity and non-parity choices, this article provides a…

Continue Reading Inspection Readiness: Defending Parity/Non-Parity Choices

Process Equivalence Protocol: Scope, Endpoints, and Acceptance Criteria

Process Equivalence Protocol: Scope, Endpoints, and Acceptance Criteria Process Equivalence Protocol: Scope, Endpoints, and Acceptance Criteria In the pharmaceutical industry, maintaining compliance and quality across manufacturing processes is paramount. The Process Equivalence Protocol (PEP) serves as a vital component for ensuring that changes in manufacturing conditions, scales, or locations do not adversely affect the quality, safety, or efficacy of the…

Continue Reading Process Equivalence Protocol: Scope, Endpoints, and Acceptance Criteria

Comparability Study Design: Sampling Density and Statistical Power

Comparability Study Design: Sampling Density and Statistical Power In pharmaceutical manufacturing, ensuring the reliability and consistency of products is paramount. A comparability study is a critical process validation tool that assesses whether a product remains equivalent following changes in its manufacturing or control processes. The design of these studies, particularly regarding sampling density and statistical power, is essential to meet…

Continue Reading Comparability Study Design: Sampling Density and Statistical Power

Change Management for Parity Changes: Evidence and Approvals

Change Management for Parity Changes: Evidence and Approvals Change Management for Parity Changes: Evidence and Approvals In the realm of pharmaceutical manufacturing, effective change management is not only a best practice but a regulatory necessity. Especially when addressing parity changes, maintaining compliance with regulatory standards set forth by agencies such as the FDA, EMA, and MHRA is paramount. This comprehensive…

Continue Reading Change Management for Parity Changes: Evidence and Approvals

Performance Verification: Bridging Studies for Non-Parity

Performance Verification: Bridging Studies for Non-Parity Performance Verification: Bridging Studies for Non-Parity In the highly regulated environment of pharmaceutical manufacturing, ensuring seamless tech transfer and equipment validation is paramount. For organizations operating under FDA process validation, EU GMP Annex 15 compliance, and rigorous internal standards, bridging studies serve as a critical component for demonstrating equivalence between different systems or processes….

Continue Reading Performance Verification: Bridging Studies for Non-Parity

Regulatory Documentation for Non-Parity: Filing Language That Works

Regulatory Documentation for Non-Parity: Filing Language That Works Regulatory Documentation for Non-Parity: Filing Language That Works This detailed tutorial aims to equip pharmaceutical professionals with a structured approach to preparing regulatory documentation concerning non-parity justifications. In a landscape governed by stringent regulations such as FDA process validation and EU GMP Annex 15, mastering the documentation for non-parity is crucial for…

Continue Reading Regulatory Documentation for Non-Parity: Filing Language That Works